He said: “I suppose that number when you hear 70 percent in conjunction with the Pfizer and Moderna ones, it could sound a bit of a disappointment.
“But, the Oxford jab is cheaper, easier to store and I’m sure there are other things we can speak to the Health Secretary about, in regards to that.”
Later on, Dan spoke to Health Secretary Matt Hancock, who soon commented on the outcome of the trial: “To get this result… that is very good news for everyone.
“Of course, we have 100 million doses of those vaccines on order and we’ve been working very closely with AstraZeneca as they increase the manufacturing of this.”
BBC Breakfast airs daily from 6am on BBC One.
